Full Description

Phase III randomised clinical trial for stage III ovarian carcinoma randomising between secondary debulking surgery with or without hyperthermic intraperitoneal chemotherapy.

Date activated: 01/03/2007 Randomised: Yes Quality of life: Yes Dutch title.

Fase III gerandomiseerde klinische studie voor patienten met stadium IIIC ovarium carcinoom waarbij gerandomiseerd wordt tussen secundaire debulking met of zonder toediening van intraperitoneale chemotherapy onder hyperthermische omstandigheden tijdens chirurgie.

 

Co├Ârdinator:

W.J. van Driel, gynaecological oncologist, NKI-AvL

Gyn Total Accrual needed: 240 Funding: CKTO

Treatment arms:

Secundary interval debulking with OVHIPEC Secondary interval debulking without OVHIPEC

Categories:

Ovarian carcinoma Phase: Phase III  Number of patients: 240